Genetic and In Vitro Inhibition of PCSK9 and Calcific Aortic Valve Stenosis
{{output}}
The authors investigated whether PCSK9 inhibition could represent a therapeutic strategy in calcific aortic valve stenosis (CAVS). A meta-analysis of 10 studies was performed to determine the impact of the PCSK9 R46L variant on CAVS, and the authors found that... ...
